* NYS Dept. of Health
HEALTH CONNECTIONS
315 464-8668 1 800 464-8668
GET with the GUIDELINES
New! University Hospital joing American Stroke Association's Get with the Guidelines initiative. The goal of the program is to improve the overall quality of care for stroke patients by improving acute stroke treatment and preventing future strokes and cardiovascular events.
|
|
University Hospital Stroke Team
Yahia M Lodi MD is a Stroke and Neurocritical Care Specialist, who specialized in stroke interventions (Endovascular Neurointerventions).
Dr. Lodi has joined the Upstate Medical University in January, 2007 as the Chief of the Cerebrovascular Program and Services (Stroke Service, Neurosciences Critical Care Service and Stroke Interventional Service) in the Department of Neurology.
Dr. Lodi completed his residency in neurology from Medical College of Wisconsin. He obtained his two years of fellowship training in Neurocritical Care and Stroke from the John Hopkins University. During his critical care fellowship at John Hopkins University, he mastered in Tranesophageal
echocardiography in evaluating cardiac hemodynamic and cardiac sources of embolism. He obtained his Neurointerventional training from the SUNY, Buffalo, NY and from the Harper University Hospital, Wayne State University, Detroit, MI. Prior to his Upstate Medical University appointment,
Dr. Lodi served as a director of Stroke and Michigan Stroke Network at St. Joseph Mercy Health System, MI. Dr. Lodi also served as a director of Endovascular Neurointervention at MSU- College of Human Medicine, East Lansing, MI. He was the director of Neurocritical Care Unit at Millard Filmore Hospital, SUNY, Buffalo, and at the University Hospital, UMDNJ-NJ Medical School. The NJ- Medical School student council nominated Dr. Lodi as one of the best teachers for the year 2003.
Dr. Lodi provides services to patients with stroke, carotid and intracranial stenosis, and cerebral aneurysm, arteriovenous malformation (AVM). The state-of-the-art catheter based technology allows him to provide treatment of ischemic stroke patients up to 8 hours of symptoms onset, who are poor candidates for intravenous thrombolytic therapy or failed intravenous therapy, and who present with stroke beyond the three hours window. This innovative catheter based technology also allows him to provide therapy for hemorrhagic stroke due to brain aneurysm by using platinum detachable coils and stent. Resent technology also allows him to treat carotid stenosis safely by using stent with a distal cerebral protection device.
Dr. Lodi has been actively involved in the experimental and clinical research in developing new catheter based therapies for acute stroke victims. His clinical research interest is cardiac dysfunction in subarachnoid hemorrhage and stroke "Neurocardiology". Dr. Lodi published numerous articles in the peer-reviewed journals and presented the results of his research in many national and international meetings. Dr. Lodi has had an opportunity of speaking in many national and international meetings as a guest speaker.
|